Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular ...

An Oakland financier, which sponsored a life sciences-focused blank-check company this summer that grossed $230 million, ...

Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne ...

By engaging with some of the most influential executives in the industry and the many organizations that advocate for them, the series will provide valuable perspectives on the evolving landscape of ...

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...

Shares in Wave rose 53% after the trial data was announced, taking its market cap above the $1 billion threshold. The company ...

PB Fintech Ltd, Globus Spirits Ltd, Glenmark Life Sciences Ltd and Dabur India Ltd are among the other losers in the BSE's 'A' group today, 25 September 2024.

Wave’s result is in line with the data that supported accelerated approval of NS Pharma’s exon 53 DMD drug Viltepso. NS ...

Report by Hays compares talent pools in 30 economies across five sectors, such as technology, engineering, manufacturing and ...

Carrier announces new CEIV Pharma certified U.S stations, underscores commitment to quality in life sciences handling.

Exceeding customer requirements provides tremendous competitive advantage for YSDSBOSTON, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tive, the global leader in supply chain and logistics visibility technology ...